Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
MEDNAX Inc Issues Q4 2012 EPS Guidance In Line With Analysts' Estimates
MEDNAX Inc announced that for the fourth quarter of 2012, it expects earnings will be in a range of $1.27 to $1.32 per share. This range assumes that total same-unit revenue for the three months ended December 31, 2012 will grow by 2.0% to 4.0% from the prior-year period. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $1.29 for the fourth quarter of 2012.
Latest Developments for MEDNAX Inc
- MEDNAX Inc Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates; Comments On Q2 2013 Same-Unit Revenue Growth-Conference Call
- MEDNAX Inc Announces Acquisition Of Neonatology Associates, Ltd
- MEDNAX Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates; Comments On Q1 2013 Total Same-Unit Revenue Growth Guidance
- Edgemont Capital Partners, L.P. Completes Sale Of South Oakland Anesthesia Associates, P.C. To MEDNAX Inc
- Share this
- Link this
- Digg this
Follow Reuters